256 related articles for article (PubMed ID: 30483484)
1. Methionine Antagonizes
Howe MD; Kordus SL; Cole MS; Bauman AA; Aldrich CC; Baughn AD; Minato Y
Front Cell Infect Microbiol; 2018; 8():399. PubMed ID: 30483484
[No Abstract] [Full Text] [Related]
2. Mutations in the promoter region of methionine transporter gene
Zhang Y; Wang S; Chen X; Cui P; Chen J; Zhang W
mBio; 2024 Feb; 15(2):e0207323. PubMed ID: 38179948
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.
Minato Y; Thiede JM; Kordus SL; McKlveen EJ; Turman BJ; Baughn AD
Antimicrob Agents Chemother; 2015 Sep; 59(9):5097-106. PubMed ID: 26033719
[TBL] [Abstract][Full Text] [Related]
4. Deletion of
Yang SS; Hu YB; Wang XD; Gao YR; Li K; Zhang XE; Chen SY; Zhang TY; Gu J; Deng JY
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717039
[TBL] [Abstract][Full Text] [Related]
5. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
[TBL] [Abstract][Full Text] [Related]
6. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis.
Chakraborty S; Gruber T; Barry CE; Boshoff HI; Rhee KY
Science; 2013 Jan; 339(6115):88-91. PubMed ID: 23118010
[TBL] [Abstract][Full Text] [Related]
7. Decreased Methylenetetrahydrofolate Reductase Activity Leads to Increased Sensitivity to
Yu JF; Xu JT; Yang SS; Gao MN; Si HR; Xiong DY; Gu J; Wu ZL; Zhou J; Deng JY
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0146521. PubMed ID: 34780266
[TBL] [Abstract][Full Text] [Related]
8. Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents.
Hajian B; Scocchera E; Shoen C; Krucinska J; Viswanathan K; G-Dayanandan N; Erlandsen H; Estrada A; Mikušová K; Korduláková J; Cynamon M; Wright D
Cell Chem Biol; 2019 Jun; 26(6):781-791.e6. PubMed ID: 30930162
[TBL] [Abstract][Full Text] [Related]
9. Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis.
Zhao F; Wang XD; Erber LN; Luo M; Guo AZ; Yang SS; Gu J; Turman BJ; Gao YR; Li DF; Cui ZQ; Zhang ZP; Bi LJ; Baughn AD; Zhang XE; Deng JY
Antimicrob Agents Chemother; 2014; 58(3):1479-87. PubMed ID: 24366731
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.
Mathys V; Wintjens R; Lefevre P; Bertout J; Singhal A; Kiass M; Kurepina N; Wang XM; Mathema B; Baulard A; Kreiswirth BN; Bifani P
Antimicrob Agents Chemother; 2009 May; 53(5):2100-9. PubMed ID: 19237648
[TBL] [Abstract][Full Text] [Related]
11. Whole genome sequencing reveals candidate genes involving in PAS resistance in M. Tuberculosis isolated from patients in Thailand.
Dokladda K; Billamas P; Jaitrong S; Suwanakitti N; Phornsiricharoenphant W; Viratyosin W; Prammananan T
World J Microbiol Biotechnol; 2023 Dec; 40(1):32. PubMed ID: 38057660
[TBL] [Abstract][Full Text] [Related]
12. [Mutations in the thymidylate synthase gene is a major mechanism in the para-aminosalicylic acid resistance of M. tuberculosis].
Zhang ZD; Zhao YL; Li ZH; Jia HY; Liu YH; Chen X; Liu ZQ; Du BP; Xing AY; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Sep; 30(9):683-5. PubMed ID: 18070553
[TBL] [Abstract][Full Text] [Related]
13. Targeting intracellular p-aminobenzoic acid production potentiates the anti-tubercular action of antifolates.
Thiede JM; Kordus SL; Turman BJ; Buonomo JA; Aldrich CC; Minato Y; Baughn AD
Sci Rep; 2016 Dec; 6():38083. PubMed ID: 27905500
[TBL] [Abstract][Full Text] [Related]
14. Multi-omics comparisons of p-aminosalicylic acid (PAS) resistance in folC mutated and un-mutated Mycobacterium tuberculosis strains.
Wei W; Yan H; Zhao J; Li H; Li Z; Guo H; Wang X; Zhou Y; Zhang X; Zeng J; Chen T; Zhou L
Emerg Microbes Infect; 2019; 8(1):248-261. PubMed ID: 30866779
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of methionine in aminosalicylate-inhibition of Mycobacterium tuberculosis.
HEDGECOCK LW
J Bacteriol; 1958 Apr; 75(4):417-21. PubMed ID: 13525346
[No Abstract] [Full Text] [Related]
16. Antagonism of the inhibitory action of aminosalicylic acid on Mycobacterium tuberculosis by methionine, biotin and certain fatty acids, amino acids, and purines.
HEDGECOCK LW
J Bacteriol; 1956 Dec; 72(6):839-46. PubMed ID: 13398375
[No Abstract] [Full Text] [Related]
17. Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations.
Wang W; Li S; Ge Q; Guo H; Shang Y; Ren W; Wang Y; Xue Z; Lu J; Pang Y
Ann Clin Microbiol Antimicrob; 2022 Nov; 21(1):48. PubMed ID: 36335391
[TBL] [Abstract][Full Text] [Related]
18. dfrA thyA Double Deletion in para-Aminosalicylic Acid-Resistant Mycobacterium tuberculosis Beijing Strains.
Moradigaravand D; Grandjean L; Martinez E; Li H; Zheng J; Coronel J; Moore D; Török ME; Sintchenko V; Huang H; Javid B; Parkhill J; Peacock SJ; Köser CU
Antimicrob Agents Chemother; 2016 Jun; 60(6):3864-7. PubMed ID: 27021327
[No Abstract] [Full Text] [Related]
19. The aminosalicylate - folate connection.
London RE
Drug Metab Rev; 2024 Feb; 56(1):80-96. PubMed ID: 38230664
[TBL] [Abstract][Full Text] [Related]
20. Thr202Ala in thyA is a marker for the Latin American Mediterranean lineage of the Mycobacterium tuberculosis complex rather than para-aminosalicylic acid resistance.
Feuerriegel S; Köser C; Trübe L; Archer J; Rüsch Gerdes S; Richter E; Niemann S
Antimicrob Agents Chemother; 2010 Nov; 54(11):4794-8. PubMed ID: 20805400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]